AR111836A2 - Extracto bacteriano para trastornos respiratorios - Google Patents

Extracto bacteriano para trastornos respiratorios

Info

Publication number
AR111836A2
AR111836A2 ARP180101407A ARP180101407A AR111836A2 AR 111836 A2 AR111836 A2 AR 111836A2 AR P180101407 A ARP180101407 A AR P180101407A AR P180101407 A ARP180101407 A AR P180101407A AR 111836 A2 AR111836 A2 AR 111836A2
Authority
AR
Argentina
Prior art keywords
respiratory disorders
bacterial extract
extract
streptococcus pyogenes
streptococcus
Prior art date
Application number
ARP180101407A
Other languages
English (en)
Inventor
Carlo Chiavaroli
Laetitia Chalvet
Jean Vigroux
Leon - Salvagni Marco Pierre
Jacques Alain Bauer
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of AR111836A2 publication Critical patent/AR111836A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicación 1: Un extracto que conserva y/o retiene componentes sacarídicos de una mezcla de una o más especies bacterianas seleccionadas a partir del grupo que consiste en: Moraxella catarrhalis, Haemophilus influenzae, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes y Streptococcus sanguinis, caracterizado porque dicho extracto comprende menos de 100 mg/ml de ácidos nucleicos y al menos 0,3 mg/ml de sacáridos.
ARP180101407A 2007-03-05 2018-05-28 Extracto bacteriano para trastornos respiratorios AR111836A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90478907P 2007-03-05 2007-03-05
PCT/US2008/055906 WO2008109669A2 (en) 2007-03-05 2008-03-05 Bacterial extract for respiratory disorders and proces for its preparation

Publications (1)

Publication Number Publication Date
AR111836A2 true AR111836A2 (es) 2019-08-21

Family

ID=39739087

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP080103705A AR070307A1 (es) 2007-03-05 2008-08-26 Extracto bacteriano para trastornos respiratorios y proceso para su preparacion
ARP180101407A AR111836A2 (es) 2007-03-05 2018-05-28 Extracto bacteriano para trastornos respiratorios

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP080103705A AR070307A1 (es) 2007-03-05 2008-08-26 Extracto bacteriano para trastornos respiratorios y proceso para su preparacion

Country Status (21)

Country Link
US (2) US8697154B2 (es)
EP (2) EP3332791A1 (es)
JP (1) JP5693010B2 (es)
KR (1) KR101527483B1 (es)
CN (1) CN101663041B (es)
AR (2) AR070307A1 (es)
AU (1) AU2008222865B2 (es)
BR (1) BRPI0808333B8 (es)
CA (1) CA2679843C (es)
DK (1) DK2114421T3 (es)
ES (1) ES2665002T3 (es)
HU (1) HUE038598T2 (es)
IL (1) IL200666A (es)
MX (1) MX2009009452A (es)
PL (1) PL2114421T3 (es)
PT (1) PT2114421T (es)
RU (1) RU2456007C2 (es)
SI (1) SI2114421T1 (es)
TW (1) TWI434693B (es)
WO (1) WO2008109669A2 (es)
ZA (1) ZA200906029B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401876D0 (sv) * 2004-07-16 2004-07-16 Forskarpatent I Syd Ab Prevention of allergy in children
GB2477752A (en) * 2010-02-11 2011-08-17 Arab Biotechnology Company Detection of bacteria
FR2969658B1 (fr) * 2010-12-22 2014-10-17 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
FR2969657B1 (fr) * 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
CN103157108B (zh) * 2011-12-13 2016-01-20 宁云山 免疫调节剂组合物及其药物组合物和应用
WO2013119170A2 (en) * 2012-02-08 2013-08-15 Premune Ab Prevention of inflammatory disorders in domestic non-human mammals
MX361647B (es) * 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
CN105779326A (zh) * 2014-12-25 2016-07-20 河南科技学院 化脓性链球菌细胞壁成分萃取方法
CN106310246A (zh) * 2016-08-31 2017-01-11 廖正芳 一种可吸入制剂及其制备方法
KR102134385B1 (ko) 2017-02-06 2020-07-16 주식회사 한국인삼공사 홍삼 추출물을 함유하는 호흡기 증상 개선용 조성물
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
AU2019434478A1 (en) * 2019-03-14 2021-09-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders
PE20212261A1 (es) 2019-03-14 2021-11-29 Om Pharma Sa Extractos bacterianos estables como farmacos
JP7356742B2 (ja) * 2019-04-26 2023-10-05 エムディー ヘルスケア インコーポレイテッド ストレプトコッカスパイオジェネス細菌由来タンパク質及びその用途
KR102437436B1 (ko) 2019-04-26 2022-08-30 주식회사 엠디헬스케어 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532790A (en) * 1968-02-23 1970-10-06 Canadian Patents Dev Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
CH633188A5 (fr) 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
IT1199301B (it) 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
CH685498A5 (fr) * 1992-02-14 1995-07-31 Om Lab Sa Extrait de macromolécules bactériennes, procédé pour sa préparation et composition pharmaceutique contenant cet extrait.
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
SI0729473T1 (en) 1993-11-17 2001-02-28 Om Pharma Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
PT983342E (pt) 1997-05-28 2007-12-13 Novartis Vaccines & Diagnostic Meio de cultura com extracto de grãos de soja comofonte de amiinoácido e não complexos proteicos de fonteanimal
US20040087020A1 (en) * 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
US20010051364A1 (en) * 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
AU754256C (en) * 1997-12-23 2004-05-20 Pfizer Ireland Pharmaceuticals Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
JP2000319294A (ja) * 1999-05-11 2000-11-21 Asahi Chem Ind Co Ltd 生物由来高分子溶液精製方法
FR2822071B1 (fr) 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
MXPA05014015A (es) * 2003-06-23 2006-03-17 Baxter Int Vacunas contra grupo y nisseria meningitidis y combinaciones meningococales del mismo.
JP2007518693A (ja) * 2003-08-18 2007-07-12 ザ バイオ バランス コーポレイション 安定な液体プロバイオティクス組成物、その調製および適用
EP1848448B8 (en) 2005-02-08 2010-09-15 Parmeggiani, Francesco Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse
KR20070122458A (ko) * 2005-02-11 2007-12-31 에이스 바이오사이언시즈 에이/에스 표재성 스트렙토코커스 뉴모니아 폴리펩티드
JP5006803B2 (ja) * 2005-03-03 2012-08-22 アラーガン、インコーポレイテッド クロストリジウム・バクテリアの培地およびクロストリジウム毒素を得るための方法
CA2601006C (en) * 2005-03-10 2012-10-23 Kyoritsu Seiyaku Corporation Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
WO2007084856A2 (en) 2006-01-13 2007-07-26 Baxter International Inc. Method for purifying polysaccharides
KR101666548B1 (ko) * 2007-03-05 2016-10-14 옴 파르마 에스아 소화계나 비뇨계 장애를 위한 박테리아 추출물 및 이를 이용한 치료방법 및 그 제조방법

Also Published As

Publication number Publication date
ES2665002T3 (es) 2018-04-24
TW200938212A (en) 2009-09-16
BRPI0808333B1 (pt) 2020-03-10
EP2114421A4 (en) 2010-09-22
US20100227013A1 (en) 2010-09-09
RU2456007C2 (ru) 2012-07-20
AU2008222865B2 (en) 2013-01-31
JP5693010B2 (ja) 2015-04-01
US8697154B2 (en) 2014-04-15
CN101663041B (zh) 2012-05-23
EP3332791A1 (en) 2018-06-13
BRPI0808333A2 (pt) 2017-05-30
IL200666A0 (en) 2010-05-17
CN101663041A (zh) 2010-03-03
HUE038598T2 (hu) 2018-10-29
WO2008109669A2 (en) 2008-09-12
AU2008222865A1 (en) 2008-09-12
US20140205693A1 (en) 2014-07-24
TWI434693B (zh) 2014-04-21
CA2679843C (en) 2018-10-02
US9463209B2 (en) 2016-10-11
PT2114421T (pt) 2018-04-17
IL200666A (en) 2016-12-29
WO2008109669A3 (en) 2008-12-18
KR20090122940A (ko) 2009-12-01
BRPI0808333B8 (pt) 2021-05-25
JP2010520302A (ja) 2010-06-10
EP2114421B1 (en) 2018-01-10
MX2009009452A (es) 2009-09-14
EP2114421A2 (en) 2009-11-11
AR070307A1 (es) 2010-03-31
SI2114421T1 (en) 2018-04-30
RU2009136577A (ru) 2011-04-10
CA2679843A1 (en) 2008-09-12
DK2114421T3 (en) 2018-04-23
KR101527483B1 (ko) 2015-06-09
PL2114421T3 (pl) 2018-07-31
ZA200906029B (en) 2010-11-24

Similar Documents

Publication Publication Date Title
AR111836A2 (es) Extracto bacteriano para trastornos respiratorios
WO2007141278A3 (en) Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
WO2016061286A3 (en) Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
WO2008108830A3 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2007116322A3 (en) Purification of bacterial antigens
WO2008069889A3 (en) Methods of treating hemolytic anemia
IL219641A (en) An immunogenic preparation containing at least 4 conjugates of s.pneunoniae capsular saccharide containing saccharides of various s.pneumoniae serotypes and various aspects related to this device
CL2009000879A1 (es) Metodo para fabricar un producto en un biorreactor que comprende cultivar microorganismos que son adaptados o mutagenizados para que exhiban por lo menos un 150% de tolerancia al producto; sistema para fabricar un producto; biorreactor.
UA97627C2 (en) Sclerotinia-resistant brassica
WO2007095316A3 (en) Compositions and methods for oligonucleotide formulations
WO2007133075A8 (en) Igf2 marker assisted selection for porcine reproductive traits
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
BRPI0911511B8 (pt) formulação de dna liofilizadas para aumentar a expressão de dna de plasmídeo
WO2010065735A3 (en) Methods and compositions for treating p.acnes
WO2005081821A3 (en) Polymorphic forms of 6-11 bicyclic ketolide derivatives
WO2007133712A3 (en) Antimicrobial therapy for bacterial infections
WO2006097233A3 (en) Determination of antibiotic resistance in staphylococcus aureus
BR112019007928A2 (pt) conjugados de bacitracina-oligômero de alginato
WO2008103751A3 (en) Antimicrobial and anti-inflammatory therapies and compositions
WO2007048059A3 (en) Method of treating clostridium difficile-associated diarrhea
MX2009007384A (es) Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.
WO2009073534A3 (en) Bicyclic ppat inhibitors as antibacterial agents
ATE518785T1 (de) System für nahrungskomponenten
WO2007143004A3 (en) Methods, compositions, and kits for treating shiga toxin associated conditions
WO2009102377A3 (en) Antibiotic tetrahydro-beta-carboline derivatives

Legal Events

Date Code Title Description
FB Suspension of granting procedure